‪Univ. Prof. Dr. Andreas Zirlik‬

Zitiert von

	Alle	Seit 2019
Zitate	7935	5122
h-index	46	37
i10-index	115	96

1300

650

325

975

200620072008200920102011201220132014201520162017201820192020202120222023202444 53 87 102 126 149 185 179 269 348 340 430 426 585 724 1028 1074 1202 478

Koautoren

Peter StachonUniversity Heart Center FreiburgBestätigte E-Mail-Adresse bei universitaets-herzzentrum.de
Peter LibbyProfessor of Medcine Harvard Medical SchoolBestätigte E-Mail-Adresse bei bwh.harvard.edu
Dennis WolfM.D.Bestätigte E-Mail-Adresse bei universitaets-herzzentrum.de
Heiko BuggerUniversitäts-Herzzentrum Freiburg-Bad KrozingenBestätigte E-Mail-Adresse bei universitaets-herzzentrum.de
Norbert GerdesProfessor for Vascular Biology, University Hospital DüsseldorfBestätigte E-Mail-Adresse bei med.uni-duesseldorf.de
Peter P. RainerAssociate Professor, Medical University of GrazBestätigte E-Mail-Adresse bei medunigraz.at
Klaus KaierInstitute of Medical Biometry and Statistics, University of Freiburg, GermanyBestätigte E-Mail-Adresse bei imbi.uni-freiburg.de
Timoteo MarchiniUniversity Heart Center Freiburg • Bad KrozingenBestätigte E-Mail-Adresse bei uniklinik-freiburg.de
David ZweikerMD PhD; Medical University of Graz, Graz, Austria; Clinic Ottakring, Vienna, Austria; IRCCS San Raffaele Hospital, Milan, ItalyBestätigte E-Mail-Adresse bei medunigraz.at
Filip SwirskiProfessor, Cardiovascular Research Institute at the Icahn School of Medicine at Mount SinaiBestätigte E-Mail-Adresse bei mssm.edu
Klaus LeyAugusta UniversityBestätigte E-Mail-Adresse bei lji.org
Felix MahfoudSaarland UniversityBestätigte E-Mail-Adresse bei uniklinikum-saarland.de
Nahrendorf MatthiasProfessor, Harvard Medical School, MGH Research Institute, CSB, RadiologyBestätigte E-Mail-Adresse bei partners.org
Ralph WeisslederProfessor, Harvard Medical SchoolBestätigte E-Mail-Adresse bei mgh.harvard.edu
Klaus ParhoferLMU MünchenBestätigte E-Mail-Adresse bei med.uni-muenchen.de
Markus SchlaichDobney Hypertension Centre - Royal Perth Hospital Campus, University of Western AustraliaBestätigte E-Mail-Adresse bei uwa.edu.au
Louisa GerhardtUniversity of Southern CaliforniaBestätigte E-Mail-Adresse bei usc.edu
Giuseppe ManciaEmeritus Professor, Università Bicocca - Milan ITALYBestätigte E-Mail-Adresse bei UNIMIB.IT
Holger WinkelsAssociate Professor, University of CologneBestätigte E-Mail-Adresse bei uk-koeln.de
James de LemosUniversity of Texas Southwestern Medical CenterBestätigte E-Mail-Adresse bei utsouthwestern.edu

Folgen

Univ. Prof. Dr. Andreas Zirlik

Head of Dept. of Cardiology, Chairman of the University Heart Center Graz, Medical University Graz

Bestätigte E-Mail-Adresse bei medunigraz.at

Interventional and structural Cardiology Inflammatory mechanisms in atherosclerosis


Titel Nach Zitationen sortieren Nach Jahr sortieren Nach Titel sortieren	Zitiert von Zitiert von	Jahr
Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells K Isoda, JL Young, A Zirlik, LA MacFarlane, N Tsuboi, N Gerdes, ... Arteriosclerosis, thrombosis, and vascular biology 26 (3), 611-617, 2006	670	2006
Ly-6C^high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium I Hilgendorf, LMS Gerhardt, TC Tan, C Winter, TAW Holderried, ... Circulation research 114 (10), 1611-1622, 2014	556	2014
Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry H Winkels, E Ehinger, M Vassallo, K Buscher, HQ Dinh, K Kobiyama, ... Circulation research 122 (12), 1675-1688, 2018	442	2018
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1 A Zirlik, C Maier, N Gerdes, L MacFarlane, J Soosairajah, U Bavendiek, ... Circulation 115 (12), 1571-1580, 2007	281	2007
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019	246	2019
First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension M Böhm, F Mahfoud, C Ukena, UC Hoppe, K Narkiewicz, M Negoita, ... Hypertension 65 (4), 766-774, 2015	233	2015
Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019	189	2019
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study A Zirlik, SM Abdullah, N Gerdes, L MacFarlane, U Schönbeck, A Khera, ... Arteriosclerosis, thrombosis, and vascular biology 27 (9), 2043-2049, 2007	167	2007
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation A Zirlik, C Bode Journal of thrombosis and thrombolysis 43 (3), 365-379, 2017	145	2017
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity I Hilgendorf, I Theurl, LMS Gerhardt, CS Robbins, GF Weber, A Gonen, ... Circulation 129 (16), 1677-1687, 2014	141	2014
Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial SJ Shah, BA Borlaug, ES Chung, DE Cutlip, P Debonnaire, PS Fail, ... The Lancet 399 (10330), 1130-1140, 2022	140	2022
TRAF-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells A Zirlik, U Bavendiek, P Libby, L MacFarlane, N Gerdes, J Jagielska, ... Arteriosclerosis, thrombosis, and vascular biology 27 (5), 1101-1107, 2007	130	2007
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study JA de Lemos, A Zirlik, U Schönbeck, N Varo, SA Murphy, A Khera, ... Arteriosclerosis, thrombosis, and vascular biology 25 (10), 2192-2196, 2005	130	2005
Nicotinamide for the treatment of heart failure with preserved ejection fraction M Abdellatif, V Trummer-Herbst, F Koser, S Durand, R Adão, ... Science translational medicine 13 (580), eabd7064, 2021	129	2021
Empagliflozin in acute myocardial infarction: the EMMY trial D von Lewinski, E Kolesnik, NJ Tripolt, PN Pferschy, M Benedikt, ... European heart journal 43 (41), 4421-4432, 2022	122	2022
Pathogenic Autoimmunity in Atherosclerosis Evolves From Initially Protective Apolipoprotein B₁₀₀–Reactive CD4⁺ T-Regulatory Cells D Wolf, T Gerhardt, H Winkels, NA Michel, AB Pramod, Y Ghosheh, ... Circulation 142 (13), 1279-1293, 2020	118	2020
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis—but does not affect immunity and thrombosis in mice D Wolf, JD Hohmann, A Wiedemann, K Bledzka, H Blankenbach, ... Circulation research 109 (11), 1269-1279, 2011	116	2011
CD40L and its receptors in atherothrombosis—an update NA Michel, A Zirlik, D Wolf Frontiers in cardiovascular medicine 4, 40, 2017	115	2017
Renal denervation in high-risk patients with hypertension F Mahfoud, G Mancia, R Schmieder, K Narkiewicz, L Ruilope, M Schlaich, ... Journal of the American College of Cardiology 75 (23), 2879-2888, 2020	108	2020
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense D Wolf, N Anto-Michel, H Blankenbach, A Wiedemann, K Buscher, ... Nature communications 9 (1), 525, 2018	95	2018

Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.

Artikel 1–20

Zitate pro Jahr

Doppelte Zitate

Zusammengeführte Zitate

Koautor hinzufügenKoautoren

Folgen

Zitiert von

Koautoren